Non-syndromic urogenital tract malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:165704
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-syndromic urogenital tract malformation (Orphanet code 165704) refers to a group of congenital structural abnormalities affecting the urinary and/or genital systems that occur in isolation, meaning they are not part of a recognized genetic syndrome or associated with malformations in other organ systems. These malformations encompass a wide spectrum of anatomical defects, including but not limited to renal agenesis, renal hypoplasia or dysplasia, duplex collecting systems, hydronephrosis due to ureteropelvic junction obstruction, vesicoureteral reflux, posterior urethral valves, hypospadias, cryptorchidism, and various uterine or vaginal anomalies. The severity ranges from mild conditions that may be incidentally discovered to life-threatening malformations that can impair renal function and require urgent intervention. These malformations primarily affect the kidneys, ureters, bladder, urethra, and reproductive organs. They are often detected prenatally through routine ultrasound screening or may present in infancy or childhood with urinary tract infections, voiding difficulties, or impaired kidney function. Some cases may not become apparent until adolescence or adulthood, particularly certain genital tract anomalies in females. The etiology is heterogeneous and may involve genetic factors, environmental influences, or a combination of both. Several genes involved in urogenital development (such as PAX2, HNF1B, RET, and others) have been implicated in some cases, though many remain without an identified genetic cause. Management depends on the specific type and severity of the malformation. Treatment options range from conservative monitoring and antibiotic prophylaxis for mild vesicoureteral reflux to surgical correction for obstructive uropathies, hypospadias, or complex renal anomalies. Long-term follow-up by a multidisciplinary team including pediatric urologists, nephrologists, and in some cases reproductive specialists is often necessary to monitor renal function and address complications. Early detection and appropriate intervention can significantly improve outcomes and quality of life.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-syndromic urogenital tract malformation.

View clinical trials →

No actively recruiting trials found for Non-syndromic urogenital tract malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-syndromic urogenital tract malformation community →

No specialists are currently listed for Non-syndromic urogenital tract malformation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-syndromic urogenital tract malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-syndromic urogenital tract malformationForum →

No community posts yet. Be the first to share your experience with Non-syndromic urogenital tract malformation.

Start the conversation →

Latest news about Non-syndromic urogenital tract malformation

No recent news articles for Non-syndromic urogenital tract malformation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Non-syndromic urogenital tract malformation

What is Non-syndromic urogenital tract malformation?

Non-syndromic urogenital tract malformation (Orphanet code 165704) refers to a group of congenital structural abnormalities affecting the urinary and/or genital systems that occur in isolation, meaning they are not part of a recognized genetic syndrome or associated with malformations in other organ systems. These malformations encompass a wide spectrum of anatomical defects, including but not limited to renal agenesis, renal hypoplasia or dysplasia, duplex collecting systems, hydronephrosis due to ureteropelvic junction obstruction, vesicoureteral reflux, posterior urethral valves, hypospadia

At what age does Non-syndromic urogenital tract malformation typically begin?

Typical onset of Non-syndromic urogenital tract malformation is neonatal. Age of onset can vary across affected individuals.